Bora Pharmaceuticals Co., LTD. (TPE:6472)
Taiwan · Delayed Price · Currency is TWD 488.00
-3.00 (-0.61%)
At close: Dec 31, 2025
TPE:6472 Market Cap
TPE:6472 has a market cap or net worth of 60.52 billion as of December 31, 2025. Its market cap has decreased by -31.98% in one year.
Market Cap
60.52B
Enterprise Value
77.67B
Revenue
21.10B
Ranking
n/a
PE Ratio
14.97
Stock Price
488.00
Market Cap Chart
Since October 3, 2014, TPE:6472's market cap has increased from 3.16B to 60.52B, an increase of 1,814.18%. That is a compound annual growth rate of 30.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 60.52B | -22.12% |
| Dec 31, 2024 | 77.71B | 20.27% |
| Dec 29, 2023 | 64.61B | 107.61% |
| Dec 30, 2022 | 31.12B | 150.04% |
| Dec 30, 2021 | 12.45B | 17.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 238.84B |
| PharmaEssentia | 179.19B |
| Lotus Pharmaceutical | 74.95B |
| Heron Neutron Medical | 70.34B |
| Lin BioScience | 33.13B |
| Lumosa Therapeutics | 31.84B |
| Center Laboratories | 29.26B |
| Oneness Biotech | 27.17B |